Bronchiectasis has been regarded as an orphan lung disease; however, the burden imposed by this disease is substantial in many countries, including Korea.[@B1] Patients with bronchiectasis often have coexisting airflow limitation, which is associated with more respiratory infections and exacerbations.[@B2][@B3]

The presence of an airflow limitation is a well-defined risk factor for postoperative pulmonary complications (PPC) in patients undergoing extra-pulmonary surgery,[@B4] leading to increased in-hospital mortality and prolonged hospital stay.[@B5] However, limited data are available to clarify whether bronchiectasis further increases PPC in patients with airflow limitation. The aim of the present study was to investigate the impact of bronchiectasis on PPC following extra-pulmonary surgery in patients with airflow limitation.

We reviewed the medical records of 1,891 adult patients referred to the pulmonary department for consultation before extra-thoracic surgery at Samsung Medical Center (a 1,979-bed referral hospital) between March 2014 and January 2015. Of these, we included 440 who showed airflow limitation (i.e., pre-bronchodilator forced expiratory volume in 1 second/forced vital capacity \< 0.7) on spirometry and had available chest computed tomography (CT) data. Three patients with asthma were not included in this study. Finally, 437 patients were included in this study. We classified the patients into two groups according to the bronchiectasis on chest CT and observed the occurrence of PPC over time. Some clinical data of the patients were included in a recently published article.[@B4]

PPC was defined as in-hospital postoperative events related to the respiratory system, such as respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, and bronchospasm (post-operative exacerbation) within the first seven postoperative days.[@B6] We also extracted preoperative data, including information regarding demographic characteristics, body mass index, smoking history, American Society of Anesthesiologists physical status, comorbidities, types of surgery, pulmonary function test, and bronchodilator use. The severity of bronchiectasis was assessed by the Bronchiectasis Severity Index (BSI).[@B7] We designated 0--4 points and ≥ 5 points as bronchiectasis of low severity and bronchiectasis of high severity, respectively.[@B7]

Of the patients, 62 (14.2%) had bronchiectasis. Women gender (32.3% vs. 16.0%, *P* = 0.004) and previous history of tuberculosis (38.7% vs. 21.6%, *P* = 0.006) were more common in patients with bronchiectasis compared to those without bronchiectasis. There were no significant intergroup differences in age, smoking history, type of surgery, pulmonary function test results, bronchodilator use, and severity of airflow limitation ([Table 1](#T1){ref-type="table"}). The median number of involved lobes was two (interquartile range, 1--3). The main type of bronchiectasis was cystic (48.4%) followed by cylindrical (30.6%) and mixed (21.0%).

The overall rate of PPC was significantly higher in patients with bronchiectasis than in those without bronchiectasis (40.3% vs. 21.6%, *P* = 0.001). The occurrence of pleural effusion (29.0% vs. 15.5%, *P* = 0.009), atelectasis (19.4% vs. 9.9%, *P* = 0.028), and post-operative exacerbation (8.1% vs. 1.3%, *P* = 0.007) was significantly higher in patients with bronchiectasis than in those without bronchiectasis, while there were no significant differences in the occurrence of pneumonia and respiratory failure between the two groups ([Fig. 1](#F1){ref-type="fig"}). The rate of PPC by bronchiectasis and BSI categories are shown in [Supplementary Fig. 1](#S1){ref-type="supplementary-material"}.

As shown in [Table 2](#T2){ref-type="table"}, bronchiectasis was associated with the occurrence of PPC (adjusted odds ratio \[aOR\] for PPC, 2.73; 95% confidence interval \[CI\], 1.47--5.06). Compared to patients without bronchiectasis, those showing bronchiectasis with low and high BSI were 2.40 (95% CI, 1.06--5.43) and 2.74 (95% CI, 1.25--6.01) fold more likely to have PPC after extra-pulmonary surgery, respectively ([Table 2](#T2){ref-type="table"}).

The ORs for PPC significantly differed with bronchodilator use; among patients who did use bronchodilators, the OR for PPC was not significantly higher in patients with bronchiectasis in comparison with that in patients without bronchiectasis. In contrast, among patients who did not use bronchodilators, the OR for PPC was significantly higher in patients with bronchiectasis compared with that in patients without bronchiectasis (aOR, 3.24; 95% CI, 1.57--6.68).

In this study, we demonstrated that the presence of bronchiectasis and its severity significantly increase the risk of PPC after extrapulmonary surgery in patients with airflow limitations. The impact of bronchiectasis on PPC was especially significant in patients who did not use bronchodilators.

Our findings were in line with the results of previous studies, which reported that the presence of bronchiectasis in chronic obstructive pulmonary disease patients is related to increased risk of post-operative exacerbation.[@B2] Our results added to the evidence of poor outcomes in patients showing coexisting bronchiectasis and airflow limitation with increased PPC after extra-thoracic surgery. Furthermore, our results indicate that patients with bronchiectasis of high severity were 2.74-fold more likely to have PPC. Thus, our study suggests that clinicians should review the presence and extent of bronchiectasis carefully before extra-thoracic surgery.

Bronchial dilation in bronchiectasis leads to impaired mucociliary clearance and failure to adequately clear mucus.[@B8] Although the exact mechanism via which bronchiectasis increases PPC in the patients with airflow limitation is not well known, altered mucociliary clearance and mucus trapping probably cause atelectasis in bronchiectasis patients by hindering sputum expectoration. Moreover, these phenomena are significantly associated with an increased incidence of post-operative exacerbations. Notably, we found that an increased risk of PPC was attenuated by bronchodilators, as shown in our previous study, where perioperative use of bronchodilators reduced the development of PPC in patients with airflow limitations.[@B4] The enhanced mucociliary clearance and effective bronchodilation with the use of bronchodilators may have restored decreased mucociliary clearance and assisted in clearing mucus in this population.[@B8] However, the rate of pneumonia and respiratory failure was similar between patients without bronchiectasis and those with bronchiectasis. Further analysis showed that patients with severe bronchiectasis had a higher rate of pneumonia and respiratory failure than those without bronchiectasis, but this finding did not reach statistical significance. This could be due to insufficient power to detect a significant difference for pneumonia and respiratory failure. Thus, well designed prospective studies with a larger sample size based on our results are needed.

This study had some limitations. First, it was retrospectively performed at a single center, which might limit the generalization of our findings to other institutions. Second, there might be selection bias because patients who performed CT were chosen from our original cohort. Third, sputum culture was performed in one-fifth of bronchiectasis patients, which might have underestimated BSI in some patients.

In conclusion, bronchiectasis was associated with an increased risk of PPC after extra-pulmonary surgery in patients with airflow limitation. Bronchodilators may reduce PPC in bronchiectasis patients with airflow limitation.
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###### Supplementary Fig. 1

The rate of PPC by BE and BSI categories.

![The rate of PPC following extra-pulmonary surgery in patients with airflow limitation according to the presence or absence of bronchiectasis.\
PPC = postoperative pulmonary complications.](jkms-35-e80-g001){#F1}

###### Baseline characteristics of the study population
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  Characteristics                  Total (n = 437)            Without bronchiectasis (n = 375)   With bronchiectasis (n = 62)   *P* value           
  -------------------------------- -------------------------- ---------------------------------- ------------------------------ ------------------- -----------
  Age, years                       69 (64--75)                70 (64--75)                        68 (64--74)                    0.544               
  Gender, men                      357 (81.7)                 315 (84.0)                         42 (67.7)                      0.004               
  Body mass index, kg/m^2^         23.3 ± 3.0                 23.3 ± 3.0                         23.4 ± 2.9                     0.758               
  Smoking history                                                                                                               0.156               
                                   Never or ex-smoker         364 (83.3)                         308 (82.1)                     56 (90.3)           
                                   Current smoker             73 (16.7)                          67 (17.9)                      6 (9.7)             
  ASA physical status, ≥ class 2   338 (77.3)                 294 (78.4)                         44 (71.0)                      0.258               
  Comorbidities                                                                                                                                     
                                   Pulmonary TB history       105 (24.0)                         81 (21.6)                      24 (38.7)           0.006
                                   Diabetes mellitus          121 (27.7)                         104 (27.7)                     17 (27.4)           1.000
                                   Hypertension               227 (51.9)                         195 (52.0)                     32 (51.6)           1.000
                                   Congestive heart failure   23 (5.3)                           20 (5.3)                       3 (4.8)             1.000
                                   Ischemic heart disease     43 (9.8)                           38 (10.1)                      5 (8.1)             0.782
  Surgery                                                                                                                                           
                                   Type of surgery                                                                                                  0.315
                                                              Heart or aorta surgery             40 (9.2)                       36 (9.6)            4 (6.5)
                                                              Laparoscopic abdominal surgery     112 (25.6)                     93 (24.8)           19 (30.7)
                                                              Open lower abdominal surgery       84 (19.2)                      67 (17.9)           17 (27.4)
                                                              Others^a^                          201 (46.0)                     179 (47.7)          22 (35.5)
                                   Emergency operation        8 (2.1)                            1 (1.6)                        9 (2.1)             1.000
  mMRC dyspnea scale ≥ 2           67 (17.9)                  15 (24.2)                          82 (18.8)                      0.314               
  Laboratory findings                                                                                                                               
                                   Albumin                    4.2 (3.9--4.5)                     4.3 (4.1--4.5)                 4.3 (4.0--4.5)      0.228
                                   White blood cell           7.9 (6.0--11.8)                    9.3 (6.6--12.7)                8.2 (6.0--11.9)     0.103
                                   ESR                        24.0 (12.0--46.0)                  29.0 (15.0--51.5)              24.5 (12.0--46.0)   0.274
                                   C-reactive protein         0.5 (0.1--4.6)                     1.6 (0.1--5.5)                 0.6 (0.1--4.7)      0.144
  Pulmonary function test                                                                                                                           
                                   FVC, L                     3.2 ± 0.8                          3.2 ± 0.8                      3.2 ± 0.8           0.841
                                   FVC, predicted             80.0 (72.0--88.0)                  83.0 (76.0--90.0)              81.0 (72.0--88.0)   0.022
                                   FEV~1~, L                  1.9 ± 0.5                          1.9 ± 0.5                      1.9 ± 0.5           0.566
                                   FEV~1~, predicted          69.0 (59.0--76.0)                  70.0 (60.0--78.0)              69.0 (59.0--76.0)   0.293
                                   FEV~1~/FVC                 0.6 (0.6--0.7)                     0.6 (0.6--0.7)                 0.6 (0.6--0.7)      0.296
  Severity of airflow limitation                                                                                                0.339               
                                   Mild                       47 (10.8)                          37 (9.9)                       10 (16.1)           
                                   Moderate                   337 (77.1)                         293 (78.1)                     44 (71.0)           
                                   Severe                     48 (11.0)                          40 (10.7)                      8 (12.9)            
                                   Very severe                5 (1.1)                            5 (1.3)                        0 (0.0)             
  Use of any bronchodilator^b^     81 (18.5)                  66 (17.6)                          15 (24.2)                      0.289               
  SpO~2~                           97.0 (95.0--98.0)          97.0 (95.0--98.0)                  97.0 (95.0--98.0)              0.224               

Data are expressed as mean ± standard deviation, median (interquartile range) or number (%).

ASA = American Society of Anesthesiologists, ESR = erythrocyte sedimentation rate, FVC = forced vital capacity, FEV~1~ = forced expiratory volume in 1 second, mMRC = modified Medical Round Council score, PPC = postoperative pulmonary complications, SpO~2~ = peripheral capillary oxygen saturation, TB = tuberculosis.

^a^Includes head and neck, neuro, breast, endocrine, vascular, orthopedic and spinal, gynecologic, urologic, ophthalmologic, and plastic surgery; ^b^Some patients used more than one bronchodilator.

###### Unadjusted and adjusted ORs for the occurrence of PPC
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  Variables                                           Univariable analysis   Multivariable analysis^a^                                           
  --------------------------------------------------- ---------------------- --------------------------- ------------ ------------- ------------ -------------
  Total population (n = 437)                                                                                                                     
                                                      Without BE (n = 375)   Ref.                        Ref.         Ref.          Ref.         
                                                      With BE^a^ (n = 62)    2.45                        1.40--2.31   2.73          1.47--5.06   
                                                                             Low BSI^b^ (n = 30)         2.10         0.96--4.59    2.40         1.06--5.43
                                                                             High BSI^b^(n = 32)         2.82         1.35--5.92    2.74         1.25--6.01
  Patients who did not use bronchodilator (n = 356)                                                                                              
                                                      Without BE (n = 309)   Ref.                        Ref.         Ref.          Ref.         
                                                      With BE^a^ (n = 47)    2.38                        1.24--4.55   3.24          1.57--6.68   
                                                                             Low BSI^b^ (n = 26)         2.03         0.86--4.76    2.40         0.98--5.89
                                                                             High BSI^b^ (n = 21)        2.87         1.16--7.11    2.95         1.15--7.61
  Patients who did use bronchodilator (n = 81)                                                                                                   
                                                      Without BE (n = 66)    Ref.                        Ref.         Ref.          Ref.         
                                                      With BE (n = 15)                                                                           
                                                                             Low BSI^b^ (n = 4)          2.88         0.38--22.08   4.48         0.36--53.44
                                                                             High BSI^b^ (n = 11)        2.40         0.65--8.89    1.41         0.27--7.39
                                                                             Overall^a^                  2.52         0.79--8.00    1.76         0.36--8.60

OR = odds ratio, CI = confidence interval, ASA = American Society of Anesthesiologists, BMI = body mass index, BE = bronchiectasis, BSI = bronchiectasis severity index, FEV~1~ = forced expiratory volume in 1 second, mMRC = modified Medical Round Council score, PPC = postoperative pulmonary complications.

^a^Adjusted for age, gender, BMI, smoking history, ASA physical status (\< class 2 and ≥ class 2), emergent operation, albumin, history of pulmonary tuberculosis, malignancy, FEV~1%~pred, mMRC (\< 2 and ≥ 2), type of operation (others vs. open abdominal, heart, and aorta surgery), and use of bronchodilator. Sputum culture was performed in 12 patients; ^b^Adjusted for the variables mentioned above^a^ except for the variables included in BSI (age, FEV~1%~pred, BMI, and mMRC).

[^1]: ^\*^Bumhee Yang and Hayoung Choi contributed equally to this work.
